Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitreomacular Interface”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT04802889
What this trial is testing

Microarchitecture of Vitreoretinal Contact

Who this might be right for
Vitreoretinal DetachmentVitreo-Retinal Adhesion
The S.N. Fyodorov Eye Microsurgery State Institution 20
Not applicableUnknownNCT02290795
What this trial is testing

Vitreopapillary Interface and Optic Disc Morphology

Who this might be right for
Posterior Vitreous DetachmentVitreomacular TractionGlaucoma+1 more
Universitaire Ziekenhuizen KU Leuven 350
Not applicableStudy completedNCT02933905
What this trial is testing

Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

Who this might be right for
Diabetic Macular EdemaVitreomacular InterfaceAnti-VEGF Treatment
Fundació Institut Germans Trias i Pujol 38
Not applicableUnknownNCT04726267
What this trial is testing

Incidence of Complete Posterior Vitreous Detachment After Trabeculectomy.

Who this might be right for
Posterior Vitreous Detachment
Khon Kaen University 46
Not applicableUnknownNCT03686436
What this trial is testing

Vitreomacular Interface Abnormalities in Diabetic Retinopathy Using OCT

Who this might be right for
on Vitreomacular Interface Abnormalities in Diabetic Retinopathy
Assiut University 50
Not applicableStudy completedNCT03680326
What this trial is testing

Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration

Who this might be right for
Vitreomacular Interface
Hospital Hietzing 43